These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10405022)

  • 1. Will genetic testing for predisposition for disease result in fatalism? A qualitative study of parents responses to neonatal screening for familial hypercholesterolaemia.
    Senior V; Marteau TM; Peters TJ
    Soc Sci Med; 1999 Jun; 48(12):1857-60. PubMed ID: 10405022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parents' experiences of newborn screening for genetic susceptibility to type 1 diabetes.
    Kerruish NJ
    J Med Ethics; 2011 Jun; 37(6):348-53. PubMed ID: 21266388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for Fragile X Syndrome: parent attitudes and perspectives.
    Skinner D; Sparkman KL; Bailey DB
    Genet Med; 2003; 5(5):378-84. PubMed ID: 14501833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parental Attitudes and Ideas Regarding Newborn Screening for Familial Hypercholesterolemia.
    Tobik K; Orland KM; Zhang X; Garcia K; Peterson AL
    Matern Child Health J; 2023 Jun; 27(6):978-983. PubMed ID: 36964843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthcare professionals' and parents' experiences of the confirmatory testing period: a qualitative study of the UK expanded newborn screening pilot.
    Moody L; Atkinson L; Kehal I; Bonham JR
    BMC Pediatr; 2017 May; 17(1):121. PubMed ID: 28482885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parents' decision-making in newborn screening: opinions, choices, and information needs.
    Lipstein EA; Nabi E; Perrin JM; Luff D; Browning MF; Kuhlthau KA
    Pediatrics; 2010 Oct; 126(4):696-704. PubMed ID: 20837593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychosocial risk associated with newborn screening for cystic fibrosis: parents' experience while awaiting the sweat-test appointment.
    Tluczek A; Koscik RL; Farrell PM; Rock MJ
    Pediatrics; 2005 Jun; 115(6):1692-703. PubMed ID: 15930234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individuals' experiences of, and responses to, a negative genetic test result for familial hypercholesterolaemia.
    Hilgart J; Mercer J; Thirlaway K
    J Health Psychol; 2013 Mar; 18(3):339-49. PubMed ID: 22517949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parents' responses to disclosure of genetic test results of their children.
    Grosfeld FJ; Beemer FA; Lips CJ; Hendriks KS; ten Kroode HF
    Am J Med Genet; 2000 Oct; 94(4):316-23. PubMed ID: 11038446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic counseling and neonatal screening for cystic fibrosis: an assessment of the communication process.
    Ciske DJ; Haavisto A; Laxova A; Rock LZ; Farrell PM
    Pediatrics; 2001 Apr; 107(4):699-705. PubMed ID: 11335747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parents' experiences 12 years after newborn screening for genetic susceptibility to type 1 diabetes and their attitudes to whole-genome sequencing in newborns.
    Kerruish N
    Genet Med; 2016 Mar; 18(3):249-58. PubMed ID: 26066540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adolescent Perceptions of Cholesterol Screening Results: "Young Invincibles" or Developing Adults?
    Gooding HC; Sheldrick RC; Leslie LK; Shah S; de Ferranti SD; Mackie TI
    J Adolesc Health; 2016 Aug; 59(2):162-70. PubMed ID: 27155960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disclosing to parents newborn carrier status identified by routine blood spot screening.
    Oliver S; Dezateux C; Kavanagh J; Lempert T; Stewart R
    Cochrane Database Syst Rev; 2004 Oct; (4):CD003859. PubMed ID: 15495068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential Psychosocial Risks of Sequencing Newborns.
    Frankel LA; Pereira S; McGuire AL
    Pediatrics; 2016 Jan; 137 Suppl 1(Suppl 1):S24-9. PubMed ID: 26729699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Qualitative Research on Expanded Prenatal and Newborn Screening: Robust but Marginalized.
    Grob R
    Hastings Cent Rep; 2019 May; 49 Suppl 1(Suppl 1):S72-S81. PubMed ID: 31268576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adults' values and attitudes about genetic testing for obesity risk in children.
    Segal ME; Polansky M; Sankar P
    Int J Pediatr Obes; 2007; 2(1):11-21. PubMed ID: 17763006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newborn screening for Duchenne muscular dystrophy: a psychosocial study.
    Parsons EP; Clarke AJ; Hood K; Lycett E; Bradley DM
    Arch Dis Child Fetal Neonatal Ed; 2002 Mar; 86(2):F91-5. PubMed ID: 11882550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acceptance of neonatal genetic screening for hereditary hemochromatosis by informed parents.
    Bassett M; Dunn C; Battese K; Peek M
    Genet Test; 2001; 5(4):317-20. PubMed ID: 11960577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis.
    Marks D; Wonderling D; Thorogood M; Lambert H; Humphries SE; Neil HA
    Health Technol Assess; 2000; 4(29):1-123. PubMed ID: 11109029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neonatal screening for treatable and untreatable disorders: prospective parents' opinions.
    Plass AM; van El CG; Pieters T; Cornel MC
    Pediatrics; 2010 Jan; 125(1):e99-106. PubMed ID: 20026497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.